Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $4.02 Million - $4.45 Million
-17,330 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$221.92 - $245.94 $218,813 - $242,496
-986 Reduced 5.38%
17,330 $4.34 Million
Q3 2020

Nov 09, 2020

SELL
$215.77 - $276.76 $431,540 - $553,520
-2,000 Reduced 9.84%
18,316 $4.27 Million
Q2 2020

Aug 03, 2020

BUY
$219.9 - $263.41 $1.04 Million - $1.24 Million
4,726 Added 30.31%
20,316 $4.86 Million
Q1 2020

May 05, 2020

SELL
$195.69 - $279.01 $93,931 - $133,924
-480 Reduced 2.99%
15,590 $3.58 Million
Q4 2019

Jan 27, 2020

BUY
$236.45 - $266.82 $307,385 - $346,866
1,300 Added 8.8%
16,070 $4.37 Million
Q3 2019

Oct 25, 2019

BUY
$230.58 - $256.08 $108,372 - $120,357
470 Added 3.29%
14,770 $3.74 Million
Q2 2019

Aug 05, 2019

BUY
$217.4 - $246.08 $108,700 - $123,040
500 Added 3.62%
14,300 $3.6 Million
Q1 2019

Apr 26, 2019

SELL
$206.05 - $248.17 $453,310 - $545,974
-2,200 Reduced 13.75%
13,800 $3.45 Million
Q4 2018

Jan 24, 2019

SELL
$204.73 - $257.93 $1.64 Million - $2.06 Million
-8,000 Reduced 33.33%
16,000 $3.61 Million
Q3 2018

Oct 26, 2018

SELL
$233.07 - $256.0 $311,148 - $341,760
-1,335 Reduced 5.27%
24,000 $6.26 Million
Q2 2018

Jul 26, 2018

SELL
$208.1 - $233.85 $27,053 - $30,400
-130 Reduced 0.51%
25,335 $6.07 Million
Q1 2018

Apr 30, 2018

BUY
$205.46 - $240.27 $1.53 Million - $1.79 Million
7,465 Added 41.47%
25,465 $5.52 Million
Q4 2017

Jan 26, 2018

BUY
$189.0 - $222.64 $756,000 - $890,560
4,000 Added 28.57%
18,000 $3.85 Million
Q3 2017

Oct 27, 2017

BUY
$186.89 - $198.9 $2.62 Million - $2.78 Million
14,000
14,000 $2.74 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.